Precigen (PGEN) Other financing activities (2012 - 2017)

Precigen (PGEN) reported Other financing activities of $10000.0 for Q1 2017, down 96.09% quarter-over-quarter from $256000.0 in Q1 2014.

Precigen (PGEN) Other financing activities (2012 - 2017) Analysis & Trends

Precigen (PGEN) has 4 years of Other financing activities data on file, last reported at $10000.0 in Q1 2017.

  • Other financing activities for Q1 2017 came in at $10000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $10000.0 (changed N/A YoY), and the FY2017 annual result was $10000.0, changed N/A from the prior year.
  • Other financing activities slipped to $10000.0 in Q1 2017 per PGEN's latest filing, from $256000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.6 million in Q2 2013 and troughed at $10000.0 in Q1 2017.
  • A 3-year average of $853500.0 and a median of $891500.0 in 2013 frame the typical range for Other financing activities.
  • On a YoY basis, Other financing activities climbed as much as 83.24% in 2014 and fell as far as 83.24% in 2014.
  • A 3-year view of Other financing activities shows it stood at $1.6 million in 2013, then tumbled by 84.21% to $256000.0 in 2014, then tumbled by 96.09% to $10000.0 in 2017.
  • Business Quant data shows PGEN's Other financing activities at $10000.0 in Q1 2017, $256000.0 in Q1 2014, and $1.6 million in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Precigen 1.27 Bn 1.27 Bn 20.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2017 10,000.00
Mar 31, 2017 10,000.00
Mar 31, 2014 256,000.00
Mar 31, 2014 256,000.00
Jun 30, 2013 1.62 Mn
Jun 30, 2013 1.62 Mn
Mar 31, 2013 1.53 Mn
Mar 31, 2013 1.53 Mn
Dec 31, 2012 5,000.00
Dec 31, 2012 5,000.00